1. Home
  2. BNR vs AIRS Comparison

BNR vs AIRS Comparison

Compare BNR & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$13.00

Market Cap

141.5M

Sector

Health Care

ML Signal

N/A

Logo AirSculpt Technologies Inc.

AIRS

AirSculpt Technologies Inc.

N/A

Current Price

$0.81

Market Cap

122.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNR
AIRS
Founded
2014
2012
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.5M
122.6M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
BNR
AIRS
Price
$13.00
$0.81
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $3.33
AVG Volume (30 Days)
23.4K
★ 1.4M
Earning Date
11-23-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $151,818,000.00
Revenue This Year
$101.46
N/A
Revenue Next Year
$14.81
$0.89
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$6.79
$0.52
52 Week High
$41.72
$6.13

Technical Indicators

Market Signals
Indicator
BNR
AIRS
Relative Strength Index (RSI) 51.21 33.96
Support Level $9.12 N/A
Resistance Level $19.10 $1.95
Average True Range (ATR) 1.26 0.18
MACD 0.16 -0.05
Stochastic Oscillator 88.67 22.21

Price Performance

Historical Comparison
BNR
AIRS

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

Share on Social Networks: